Impact of a hospital-based therapeutic interchange program on patients' medication access and use after discharge

P and T

Volumn 26, Issue 3, 2001, Pages 151-161

  Galt, K A ^a   Sodorff, M M ^a   Galt, M A ^a   Lambrecht, J E ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; EXPERIENCE; HEALTH CARE ACCESS; HEALTH PROGRAM; HOSPITAL DISCHARGE; OUTCOMES RESEARCH; OUTPATIENT; PATIENT CARE;

EID: 0035081308     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Formulary management: Antibiotic and therapeutic interchange
2. Outcomes and cost savings of an ACE inhibitor therapeutic interchange
3. Measuring the impact of a formulary decision: Conversion to one quinolone agent
4. Experience with a two-tiered therapeutic interchange policy
5. Therapeutic interchange in Minnesota hospital pharmacies
6. Proton pump inhibitor therapeutic interchange: Patient expectations and satisfaction rating
7. The quality of care. How can it be assessed?
8. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly